Pulmonary Tuberculosis
📧 Sign up to get email alerts when something new happens for Pulmonary Tuberculosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BLMZ Chinese Cohort [Phase 3]
Phase 3 trial update evaluating a shorter, all-oral, precision treatment regimen for rifampicin-resistant tuberculosis in a Chinese cohort; …
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: A PAN-USR TB Multi-Center Trial [Phase 3]
A Phase 3 multicenter clinical trial for pulmonary tuberculosis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: The INSTITUT Study Tuberculosis Nutritional Support
The INSTITUT study evaluating nutritional support in patients with pulmonary tuberculosis and undernutrition has completed.
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: PanACEA - STEP2C -01 [Phase 2]
Phase 2 trial STEP2C-01 by PanACEA is currently recruiting for Pulmonary Tuberculosis and Other Specified Pulmonary Tuberculosis.
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: ATORvastatin in Pulmonary TUBerculosis [Phase 2]
Phase 2 clinical trial testing atorvastatin as an adjunct therapy in pulmonary tuberculosis is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS other · 2025-09-25Clinical Trial Update: A Study on the Short - Course Treatment Regimen Containing Pretomanid for Diabetes Mellitus Complicated With Rifampicin - Resistant/Multidrug - Resistant Pulmonary Tuberculosis
Clinical trial update on a short-course pretomanid-containing regimen for rifampicin-resistant/multidrug-resistant pulmonary tuberculosis in…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Diagnostic Accuracy of CAD4TB and C-reactive Protein Assay as Triage Tests for Pulmonary Tuberculosis
A completed clinical trial evaluated the diagnostic accuracy of CAD4TB software and a C-reactive protein assay as triage tests for pulmonary…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: I-FALMIN Albumin Supplement for Patients With Pulmonary Tuberculosis [NA]
Clinical trial update for I-FALMIN albumin supplement in patients with pulmonary tuberculosis and hypoalbuminemia. The study is currently ac…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Short-course Regimens for the Treatment of Pulmonary Tuberculosis [Phase 2, Phase 3]
ClinicalTrials.gov update on Phase 2 and Phase 3 trials evaluating short-course regimens for pulmonary tuberculosis and latent tuberculosis …
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: Evaluation of PATHFAST-LAM as a Tuberculosis Treatment Monitoring Tool in Kenya
A clinical trial evaluating PATHFAST-LAM as a treatment-monitoring tool for tuberculosis in Kenya, with status not yet recruiting.
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Study About Drug Resistance of Mycobacterium Tuberculosis
A Sohag University–sponsored clinical trial is studying drug resistance in Mycobacterium tuberculosis affecting pulmonary and extrapulmonary…
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BDLL Chinese Cohort [Phase 3]
This update describes a Phase 3 clinical trial evaluating a shorter, all-oral, precise treatment regimen for rifampicin-resistant tuberculos…
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: Xpert MTB/RIF Ultra Trial [NA]
This clinical trial update indicates that the Xpert MTB/RIF Ultra diagnostic trial for tuberculosis has completed.
-
CLINICAL_TRIALS trial_result · 2025-08-21Clinical Trial Update: A Phase 2 Trial to Evaluate the EBA, Safety and Tolerability of Eto Alone and in Combination With BVL-GSK098 [Phase 2]
Phase 2 trial evaluating Eto (ethambutol) alone and in combination with BVL-GSK098 for rifampicin- and isoniazid-susceptible pulmonary tuber…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: Short-Course Regimen With Bedaquiline, Moxifloxacin and Pyrazinamide for Early Bactericidal Activity in Drug-Susceptible Tuberculosis [Phase 2]
Phase 2 trial evaluating a short-course regimen with bedaquiline, moxifloxacin, and pyrazinamide for early bactericidal activity in drug-sus…
-
CLINICAL_TRIALS trial_result · 2025-08-15Clinical Trial Update: INSTI's For The Management of HIV-associated TB [Phase 2]
Phase 2 trial evaluating an integrase inhibitor (INSTI)–based regimen for HIV-associated tuberculosis has completed enrollment and posted re…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: Evaluating a Shorter, Rifampicin-Based Treatment for People With Less Severe Tuberculosis Disease [Phase 3]
This document reports an update on a Phase 3 clinical trial evaluating a shorter rifampicin-based treatment for people with less severe tube…
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: Ultra-Short Regimen for Elderly DS-TB [Phase 3]
A Phase 3 clinical trial evaluating an ultra-short regimen for elderly patients with drug-susceptible pulmonary tuberculosis is not yet recr…
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: Breathing Exercise and Tele-Nursing Support for Patients With Tuberculosis: A Single-Group Experimental Study [NA]
A completed, single-group experimental study assessing the impact of breathing exercises and tele-nursing support on quality of life in pati…
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: Evaluating the Early Bactericidal Activity, Safety and Tolerability of Nebulised RESP301 in Adults With Tuberculosis [Phase 2]
A Phase 2 study evaluating the early bactericidal activity, safety, and tolerability of nebulised RESP301 in adults with rifampicin-suscepti…
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Study to Evaluate Safety, Tolerability, and the PK Profile of TBI-223 in Healthy Subjects [Phase 1]
A Phase 1 study evaluating safety, tolerability, and pharmacokinetics of TBI-223 in healthy subjects has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults [Phase 1]
A Phase 1 trial update reports on safety, tolerability, and pharmacokinetics assessment of the TB drug candidate TBAJ-876 in healthy adults,…
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: Nyaditum Resae® as a Co-adjuvant During Treatment for Active Pulmonary Tuberculosis and Its Impact on the Gut Microbiota [NA]
This clinical trial update describes a study evaluating Nyaditum Resae as a co-adjuvant during active pulmonary tuberculosis treatment and i…
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: Perioperative Risk Factors Related to the Prognosis of Lung Transplantation: A Retrospective Study
A Zhejiang University-sponsored retrospective study examines perioperative risk factors that influence prognosis after lung transplantation.
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: Characterization of Tuberculosis Associated Lung Fibrosis and Respiratory Impairment, and Prevention Using Doxycycline [Phase 2]
A Phase 2 trial led by Makerere University is investigating doxycycline to characterize and prevent tuberculosis-associated lung fibrosis an…